BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 27590374)

  • 21. Effect of probiotics on vaginal health in pregnancy. EFFPRO, a randomized controlled trial.
    Gille C; Böer B; Marschal M; Urschitz MS; Heinecke V; Hund V; Speidel S; Tarnow I; Mylonas I; Franz A; Engel C; Poets CF
    Am J Obstet Gynecol; 2016 Nov; 215(5):608.e1-608.e7. PubMed ID: 27342046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
    Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
    J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of an oral probiotic to reduce antepartum group B Streptococcus colonization and gastrointestinal symptoms.
    Hanson L; VandeVusse L; Forgie M; Malloy E; Singh M; Scherer M; Kleber D; Dixon J; Hryckowian AJ; Safdar N
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100748. PubMed ID: 36108911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Supplementation of Probiotics in Pregnant Women Targeting Group B Streptococcus Colonization: A Systematic Review and Meta-Analysis.
    Menichini D; Chiossi G; Monari F; De Seta F; Facchinetti F
    Nutrients; 2022 Oct; 14(21):. PubMed ID: 36364782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of 6 years of group B streptococcus (GBS) screening in near-term pregnant women].
    Honderlick P; Gravisse J; Cahen P; Vignon D
    Pathol Biol (Paris); 2010 Apr; 58(2):144-6. PubMed ID: 19892482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaginal-perianal or vaginal-perineal compared with vaginal-rectal culture-based screening for Group B Streptococci (GBS) colonization during the third trimester of pregnancy: a systematic review and meta-analysis.
    Nadeau HCG; Bisson C; Chen X; Zhao YD; Williams M; Edwards RK
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):204. PubMed ID: 35287615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Risk factors and screening strategy for group B streptococcal colonization in pregnant women: results of a prospective study].
    Jauréguy F; Carton M; Teboul J; Butel MJ; Panel P; Ghnassia JC; Doucet-Populaire F
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):132-8. PubMed ID: 12717304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of Hitchens-Pike-Todd-Hewitt medium for group B streptococcus screening in pregnant women.
    de Melo SC; Gavena AA; Silva FT; Moreira RC; de Lima Scodro RB; Cardoso RF; Siqueira VL; de Pádua RA; Carvalho MD; Pelloso SM
    PLoS One; 2015; 10(4):e0123988. PubMed ID: 25881083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genital tract group B streptococcal colonization in pregnant women: a South Indian perspective.
    Sharmila V; Joseph NM; Arun Babu T; Chaturvedula L; Sistla S
    J Infect Dev Ctries; 2011 Aug; 5(8):592-5. PubMed ID: 21841303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy.
    Kwatra G; Adrian PV; Shiri T; Buchmann EJ; Cutland CL; Madhi SA
    PLoS One; 2014; 9(6):e98778. PubMed ID: 24979575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic effect between two bacteriocin-like inhibitory substances produced by Lactobacilli Strains with inhibitory activity for Streptococcus agalactiae.
    Ruíz FO; Gerbaldo G; García MJ; Giordano W; Pascual L; Barberis IL
    Curr Microbiol; 2012 Apr; 64(4):349-56. PubMed ID: 22231454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of prenatal use of oral Clostridium butyricum on maternal group B Streptococcus colonization: A retrospective study.
    Lai TJ; Wang YH; Chong E; Lin YM; Huang CC; Feng KJ; Teng SW
    Taiwan J Obstet Gynecol; 2021 May; 60(3):442-448. PubMed ID: 33966725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral probiotics and the female urinary microbiome: a double-blinded randomized placebo-controlled trial.
    Wolff BJ; Price TK; Joyce CJ; Wolfe AJ; Mueller ER
    Int Urol Nephrol; 2019 Dec; 51(12):2149-2159. PubMed ID: 31535332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotic Lactobacilli for urogenital health in women.
    Reid G
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S234-6. PubMed ID: 18685506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of oral probiotics on vaginal Group B Streptococcal colonisation rates in pregnant women: A pilot randomised control study.
    Olsen P; Williamson M; Traynor V; Georgiou C
    Women Birth; 2018 Feb; 31(1):31-37. PubMed ID: 28668229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of Lactobacillus on group B streptococcal interactions with cells of the extraplacental membranes.
    Shiroda M; Aronoff DM; Gaddy JA; Manning SD
    Microb Pathog; 2020 Nov; 148():104463. PubMed ID: 32828901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The recurrence risk of group B Streptococcus in consecutive deliveries.
    Rottenstreich M; Rotem R; Srebnik N; Farkash R; Samueloff A; Grisaru-Granovsky S
    J Matern Fetal Neonatal Med; 2020 Jul; 33(13):2263-2268. PubMed ID: 30614306
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation.
    Martinez RC; Seney SL; Summers KL; Nomizo A; De Martinis EC; Reid G
    Microbiol Immunol; 2009 Sep; 53(9):487-95. PubMed ID: 19703242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encapsulation and subsequent freeze-drying of Lactobacillus reuteri CRL 1324 for its potential inclusion in vaginal probiotic formulations.
    Juárez Tomás MS; De Gregorio PR; Leccese Terraf MC; Nader-Macías ME
    Eur J Pharm Sci; 2015 Nov; 79():87-95. PubMed ID: 26299342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.